SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-19-107838
Filing Date
2019-04-16
Accepted
2019-04-16 16:15:03
Documents
8
Effectiveness Date
2019-04-16

Document Format Files

Seq Description Document Type Size
1 DEFA14A d735205ddefa14a.htm DEFA14A 43859
2 GRAPHIC g735205dsp005.jpg GRAPHIC 228364
3 GRAPHIC g735205dsp006.jpg GRAPHIC 450891
4 GRAPHIC g735205dsp007.jpg GRAPHIC 168046
5 GRAPHIC g735205dsp008.jpg GRAPHIC 163460
6 GRAPHIC g735205dsp009.jpg GRAPHIC 70944
7 GRAPHIC g735205dsp010.jpg GRAPHIC 63876
8 GRAPHIC g735205g0413012440879.jpg GRAPHIC 2212
  Complete submission text file 0001193125-19-107838.txt   1626667
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-16174 | Film No.: 19751131
SIC: 2834 Pharmaceutical Preparations